CIK 0001788028
- Non-accelerated filer
- Smaller reporting company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842984849
- Phone
- +1 650-549-1400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise FORMER OFFICER acquired 2,300,000 shares (option exercise)
- 4 Option exercise FORMER DIRECTOR acquired 2,300,000 shares (option exercise)
- 4 Option exercise FORMER DIRECTOR AND OFFICER acquired 2,300,000 shares (option exercise)
- 4 Option exercise 10% owner acquired 2,300,000 shares (option exercise)
- 4 Open-market sale 10% owner sold 152,883 shares at $9.92 ($1,516,599)
- 4 Open-market sale 10% owner sold 2,060 shares at $9.97 ($20,538)
- 4 Open-market sale 10% owner sold 12,810 shares at an average $10.46 ($134,005)
- 4 Open-market sale 10% owner sold 212 shares at $10.40 ($2,205)
- 4 Open-market sale 10% owner sold 101 shares at $10.40 ($1,050)
- 4 Open-market sale 10% owner sold 10,000 shares at $10.25 ($102,500)
- 4 Open-market sale 10% owner sold 93 shares at $10.25 ($953)
- 4 Open-market sale 10% owner sold 20,000 shares at an average $10.18 ($203,500)
- 4 Open-market sale 10% owner sold 20,000 shares at an average $10.10 ($202,000)
- 4 Open-market sale 10% owner sold 12 shares at an average $10.67 ($128)
- 4 Open-market sale 10% owner sold 1,000 shares at $10.00 ($10,000)
Page 7 of 8 · 158 filings